phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Blood Biomarker Points to Increased Risk of Brain Metastasis in Patients with Inflammatory Breast Cancer

* Brain metastases are a common complication of inflammatory breast cancer * High levels of soluble E-cadherin in the blood are associated with increased brain metastasis in these patients * A CXCR2 inhibitor reduced metastasis and improved survival in preclinical models, suggesting that targeting this pathway could prevent or treat brain metastasis

January 28, 2026


January 29 2026

January 28 2026

January 27 2026

January 26 2026

January 25 2026

January 24 2026

January 23 2026

January 22 2026

January 21 2026

January 20 2026

January 19 2026

January 18 2026

January 17 2026

January 16 2026

January 15 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy